Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- YPSN.SW
- Price
- 320.00
- Stock movement up
- +1.50 (0.47%)
- Company name
- Ypsomed Holding AG
- Exchange
- (SW ,
- Currency
- CHF )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 4.37B
- Ent value
- 4.78B
- Price/Sales
- 4.71
- Price/Book
- 6.98
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -86.63%
- Trailing P/E
- 33.06
- Forward P/E
- 60.49
- PEG
- -
- EPS growth
- 3.77%
- 1 year return
- -13.75%
- 3 year return
- 25.70%
- 5 year return
- 20.68%
- 10 year return
- 13.43%
Last updated: 2025-04-12
DIVIDENDS
YPSN.SW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 33.06 |
| Price to OCF | 17.27 |
| Price to FCF | - |
| Price to EBITDA | 18.72 |
| EV to EBITDA | 20.48 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.71 |
| Price to Book | 6.98 |
| EV to Sales | 5.15 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 13.65M |
| EPS (TTM) | 9.68 |
| FCF per share (TTM) | -3.67 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 928.28M |
| Gross profit (TTM) | 301.77M |
| Operating income (TTM) | 113.88M |
| Net income (TTM) | 132.12M |
| EPS (TTM) | 9.68 |
| EPS (1y forward) | 5.29 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 32.51% |
| Operating margin (TTM) | 12.27% |
| Profit margin (TTM) | 14.23% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 74.02M |
| Net receivables | 128.03M |
| Total current assets | 337.94M |
| Goodwill | 0.00 |
| Intangible assets | 281.58M |
| Property, plant and equipment | 831.14M |
| Total assets | 1.10B |
| Accounts payable | 30.88M |
| Short/Current long term debt | 256.00M |
| Total current liabilities | 440.22M |
| Total liabilities | 483.66M |
| Shareholder's equity | 625.47M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 252.91M |
| Capital expenditures (TTM) | 303.05M |
| Free cash flow (TTM) | -50.15M |
| Dividends paid (TTM) | 43.44M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 21.12% |
| Return on Assets | 12.00% |
| Return on Invested Capital | 14.99% |
| Cash Return on Invested Capital | -5.69% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 322.50 |
| Daily high | 324.00 |
| Daily low | 315.50 |
| Daily Volume | 12K |
| All-time high | 437.00 |
| 1y analyst estimate | 426.00 |
| Beta | 0.97 |
| EPS (TTM) | 9.68 |
| Dividend per share | - |
| Ex-div date | 1 Jul 2024 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| YPSN.SW | S&P500 | |
| Current price drop from All-time high | -26.77% | -12.89% |
| Highest price drop | -79.18% | -56.47% |
| Date of highest drop | 4 Aug 2011 | 9 Mar 2009 |
| Avg drop from high | -42.19% | -11.07% |
| Avg time to new high | 35 days | 12 days |
| Max time to new high | 2789 days | 1805 days |
COMPANY DETAILS
Marketcap
4.37B
Marketcap category
Mid-cap
Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Employees
2296
Website
Investor relations
-
SEC filings
CEO
Country
Switzerland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found